4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0000899243-16-031602
Director disposed of 300,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Canaan IX L.P. Director | 2016-10-11 | Other disposition | −300,000 | 3,944,381 | I: show line 1 in the form |
Loading xslF345X03/doc4.xml…